Ramji Rajendran: Ascension Alexian Brothers Medical Center Approved for Brain Metastases Imaging Trial
Ramji Rajendran, Radiation Oncologist at Radiation Oncology Consultants, posted the following on LinkedIn:
“Ascension Alexian Brothers Medical Center and Radiation Oncology Consultants have recently gained approval to participate in Radiopharm Theranostics’ RAD 101 PIIb imaging trial. With over 20 years of experience in Stereotactic Radiosurgery, we are able to provide a clinical trial for imaging brain metastases that have recurred or are undergoing radiation necrosis.
RAD 101 is a novel imaging small molecule that targets fatty acid synthase (FASN), which is overexpressed in many solid tumors including brain metastasis. The open-label, single dose, single arm multicenter US study aims to establish the imaging performance of 18F-tagged RAD 101 in participants with suspected recurrent brain metastases from solid tumors of different origins. Enrollment is anticipated to commence in Q4 2024.
We hope to provide our patients with the most cutting-edge theranostics and radiopharmaceuticals.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023